2020 EANO/ESMO临床实践指南：原发性和继发性脑肿瘤神经血管并发症的预防，诊断，治疗和随访

2020-11-19 欧洲神经肿瘤协会 Ann Oncol . 2020 Nov 19;

2020年11月，欧洲神经肿瘤协会(EANO)联合欧洲肿瘤内科学会(ESMO)共同发布了原发性和继发性脑肿瘤神经血管并发症的预防，诊断，治疗和随访指南。中枢神经系统受许多原发性脑肿瘤和其他器官肿瘤脑转

中文标题：

英文标题：

Neurological and vascular complications of primary and secondary brain tumours: EANO-ESMO Clinical Practice Guidelines for prophylaxis, diagnosis, treatment and follow-up

发布机构：

欧洲神经肿瘤协会

发布日期：

2020-11-19

简要介绍：

2020年11月，欧洲神经肿瘤协会(EANO)联合欧洲肿瘤内科学会(ESMO)共同发布了原发性和继发性脑肿瘤神经血管并发症的预防，诊断，治疗和随访指南。中枢神经系统受许多原发性脑肿瘤和其他器官肿瘤脑转移的影响。本文主要针对原发性和继发性脑肿瘤神经血管并发症的预防，诊断，治疗和随访提供指导意见。

相关资料下载：

GetToolGuiderByIdResponse(projectId=1, id=37ee11c00201859f, title=2020 EANO/ESMO临床实践指南：原发性和继发性脑肿瘤神经血管并发症的预防，诊断，治疗和随访, enTitle=Neurological and vascular complications of primary and secondary brain tumours: EANO-ESMO Clinical Practice Guidelines for prophylaxis, diagnosis, treatment and follow-up, guiderFrom=Ann Oncol . 2020 Nov 19;, authorId=0, author=, summary=2020年11月，欧洲神经肿瘤协会(EANO)联合欧洲肿瘤内科学会(ESMO)共同发布了原发性和继发性脑肿瘤神经血管并发症的预防，诊断，治疗和随访指南。中枢神经系统受许多原发性脑肿瘤和其他器官肿瘤脑转, cover=https://img.medsci.cn/2020121/1606753484065_2020535.png, journalId=0, articlesId=null, associationId=1036, associationName=欧洲神经肿瘤协会, associationIntro=null, copyright=0, guiderPublishedTime=Thu Nov 19 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>2020年11月，欧洲神经肿瘤协会(EANO)联合欧洲肿瘤内科学会(ESMO)共同发布了原发性和继发性脑肿瘤神经血管并发症的预防，诊断，治疗和随访指南。中枢神经系统受许多原发性脑肿瘤和其他器官肿瘤脑转移的影响。本文主要针对原发性和继发性脑肿瘤神经血管并发症的预防，诊断，治疗和随访提供指导意见。</p> </div> </div> </div> <div class="box_info" style="color: #373737;"> </div>, tagList=[TagDto(tagId=2797, tagName=脑肿瘤)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=25, categoryName=神经外科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=20620, categoryName=肿瘤医学网, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=2797, guiderKeyword=脑肿瘤, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=6627, appHits=61, showAppHits=0, pcHits=425, showPcHits=6566, likes=0, shares=2, comments=7, approvalStatus=1, publishedTime=Mon Nov 30 00:34:04 CST 2020, publishedTimeString=2020-11-19, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=4, createdBy=null, createdName=qiushida2, createdTime=Mon Nov 30 23:45:24 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Fri Jan 05 07:30:51 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=原发性和继发性脑肿瘤神经血管并发症的预防.pdf)])

原发性和继发性脑肿瘤神经血管并发症的预防.pdf

下载请点击：

评论区 (4)

#插入话题

插入图片

[GetPortalCommentsPageByObjectIdResponse(id=1204006, encodeId=dbd61204006d2, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59ec5389007, createdName=ms5000000541075057, createdTime=Sat Mar 19 12:01:49 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=949175, encodeId=c76a9491e525, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34253021797, createdName=liyou0510, createdTime=Thu Mar 18 09:50:01 CST 2021, time=2021-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903913, encodeId=0582903913a5, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201201/cade54d2b9b64947848f5d0b9b288c9a/6c5d0b4cc9cd44a7851dffb52b24dc89.jpg, createdBy=fdb44694234, createdName=392534278, createdTime=Tue Dec 01 16:23:24 CST 2020, time=2020-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903787, encodeId=64bd903e8740, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04745411455, createdName=ms3000000546723755, createdTime=Tue Dec 01 10:07:58 CST 2020, time=2020-12-01, status=1, ipAttribution=)]
2022-03-19 ms5000000541075057

学习了

45 0
[GetPortalCommentsPageByObjectIdResponse(id=1204006, encodeId=dbd61204006d2, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59ec5389007, createdName=ms5000000541075057, createdTime=Sat Mar 19 12:01:49 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=949175, encodeId=c76a9491e525, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34253021797, createdName=liyou0510, createdTime=Thu Mar 18 09:50:01 CST 2021, time=2021-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903913, encodeId=0582903913a5, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201201/cade54d2b9b64947848f5d0b9b288c9a/6c5d0b4cc9cd44a7851dffb52b24dc89.jpg, createdBy=fdb44694234, createdName=392534278, createdTime=Tue Dec 01 16:23:24 CST 2020, time=2020-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903787, encodeId=64bd903e8740, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04745411455, createdName=ms3000000546723755, createdTime=Tue Dec 01 10:07:58 CST 2020, time=2020-12-01, status=1, ipAttribution=)]
2021-03-18 liyou0510

学习了

63 0
[GetPortalCommentsPageByObjectIdResponse(id=1204006, encodeId=dbd61204006d2, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59ec5389007, createdName=ms5000000541075057, createdTime=Sat Mar 19 12:01:49 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=949175, encodeId=c76a9491e525, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34253021797, createdName=liyou0510, createdTime=Thu Mar 18 09:50:01 CST 2021, time=2021-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903913, encodeId=0582903913a5, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201201/cade54d2b9b64947848f5d0b9b288c9a/6c5d0b4cc9cd44a7851dffb52b24dc89.jpg, createdBy=fdb44694234, createdName=392534278, createdTime=Tue Dec 01 16:23:24 CST 2020, time=2020-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903787, encodeId=64bd903e8740, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04745411455, createdName=ms3000000546723755, createdTime=Tue Dec 01 10:07:58 CST 2020, time=2020-12-01, status=1, ipAttribution=)]
2020-12-01 392534278

学习

104 0
[GetPortalCommentsPageByObjectIdResponse(id=1204006, encodeId=dbd61204006d2, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59ec5389007, createdName=ms5000000541075057, createdTime=Sat Mar 19 12:01:49 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=949175, encodeId=c76a9491e525, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34253021797, createdName=liyou0510, createdTime=Thu Mar 18 09:50:01 CST 2021, time=2021-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903913, encodeId=0582903913a5, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201201/cade54d2b9b64947848f5d0b9b288c9a/6c5d0b4cc9cd44a7851dffb52b24dc89.jpg, createdBy=fdb44694234, createdName=392534278, createdTime=Tue Dec 01 16:23:24 CST 2020, time=2020-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903787, encodeId=64bd903e8740, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04745411455, createdName=ms3000000546723755, createdTime=Tue Dec 01 10:07:58 CST 2020, time=2020-12-01, status=1, ipAttribution=)]
2020-12-01 ms3000000546723755

学习

87 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

肿瘤科指南

2020 EANO/ESMO临床实践指南：原发性和继发性脑肿瘤神经血管并发症的预防，诊断，治疗和随访

相关指南

拓展阅读

科室

工具

服务